chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms  Shot January 10 Sore arm Fever headache cough 7 days Brain fog  persistent headaches No period   February  lymph nodes under the armpit 3 days  Persistent headaches  No period   March Persistent headaches  No period  One day of blood clots Er visit for upper gi severe pain ct clear   April  Headaches worsening  No period   May  Headaches worsening  No period  Tremors in right hand ER VISIT  migraine meds given no change   June  Headaches worsening No Period  Stuttering and speech difficulty 6 10 15 16 dizziness and vomiting 6 10 difficult with walking Pain behind eyes moving side to side and up and down 6/19  carbonated sodas are flat can?t feel Carbonation in my mouth   July  Worsening head pain  Consistent stutter Intermittent problems with walking July 5th hard time gripping items and equilibrium off.   Treatments. EEG shows diffuse brain dysfunction, VERS shows optic nerve information. Intercranial pressure increased. No changes still testing
Mon. March 15 Day 8 after vaccine- Dizzy, stomach cramps, diarrhea, red rash on upper left arm Tues. March 17 Da y 9 - Fatigue, stomach cramps diarrhea, red rash on upper arm in a larger area We?d. March 18 Day 10 - Fatigue,  stomach cramps, diarrhea, red rash in a larger area on upper arm, nausea
Fever temperature 103 within 8 hours of immunization.  Tylenol given, responded nicely.  Today temperature 105, did start with very slight nasal congestion today.  No family ill, no daycare.
103 fever persisted >12 hours, pain at injection site >72 hours, whole bode stiffness ~24 hours after onset of fever upon waking day after injection
Swelling, erythema, induration, fever 102.5 began treatment with Keflex 1000mg tid for cellulitis/fasculitis. The follow up received on 12/23/03 states the pt comes in today for follow-up visit after having had a local reaction to her Pneumovax vaccination. She had been seen on November 1 at our office by Dr who diagnosed a mild cellulitis. The pt had episode of fever with chills prior to her arm swelling and having increasing area of erythema along her right upper arm. She was treated with Keflex 1g t.i.d. for ten days. She said that she has tolerated this medicine well and that she has noticed marked improvement in her right upper arm. She now just has very small area of mild erythema present on her right upper arm.  Cellulitis of right upper extremity, resolving with current treatment.
tested positive for COVID-19 on 31Jul2022; 0.2ml in left thigh/vastis lateralis; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team, Program ID: (159558).  An 1-year-old male patient received BNT162b2 (BNT162B2), on 23Jul2022 as dose 1 (maroon cap), 0.2 ml single (Lot number: FT9142, Expiration Date: Sep2022) at the age of 1 years, in left thigh for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 23Jul2022, outcome "unknown", described as "0.2ml in left thigh/vastis lateralis"; COVID-19 (non-serious) with onset 31Jul2022, outcome "not recovered", described as "tested positive for COVID-19 on 31Jul2022". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller was a physician on behalf of a 1-year-old male patient. The patient received the first dose of the Pfizer-BioNTech COVID-19 Vaccine (6 months to 4 years formulation, maroon cap) on 23Jul2022. Then the patient had a COVID exposure and tested positive for COVID-19 on 31Jul2022. Caller asked for more information on the timing of the second and third doses. She was aware that the CDC considers the second dose to be valid when given up to 8 weeks apart from the first dose, but she wanted to know if she should continue with the vaccination schedule or restart it if the parents wanted to vaccinate their child after more than 8 weeks. Caller states she doesn't think he got COVID from the vaccine, contracted virus after coming in contact with someone with COVID, tested positive a week after getting his first dose. Caller was seeking information about when to give the subsequent doses of the vaccine since the patient tested positive.  No follow-up attempts are needed. No further information is expected.
Gave the bivalent dose for the 1st in series instead of the monovalent dose
Information has been received from a certified medical assistant (C.M.A.) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 30-JAN-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # K014798 (expiration date 12-MAR-2016, dose and route not reported). No adverse effects  were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
had nightmares; very weak; nauseated; fever; tired; left arm was sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of AXILLARY PAIN (left arm was sore), NIGHTMARE (had nightmares), ASTHENIA (very weak), NAUSEA (nauseated) and PYREXIA (fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 25-Feb-2021, the patient experienced AXILLARY PAIN (left arm was sore). On 26-Feb-2021, the patient experienced NIGHTMARE (had nightmares), ASTHENIA (very weak), NAUSEA (nauseated), PYREXIA (fever) and FATIGUE (tired). The patient was treated with ONDANSETRON 26-Feb-2021 for Nauseated, at a dose of 1 dosage form.   On 26-Feb-2021, AXILLARY PAIN (left arm was sore), NIGHTMARE (had nightmares), ASTHENIA (very weak), NAUSEA (nauseated) and PYREXIA (fever) had resolved. On 27-Feb-2021, FATIGUE (tired) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 101.5 (High) 101.5 F. On 26-Feb-2021, Oxygen saturation: 98% (normal) 98%. On 26-Feb-2021, Respiratory rate: 16 (normal) 16.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Shot at 0710 on 1/25 First chill at 1900 Full blown frozen chills at 2310 Woke up HOT + fever @ 0215 ~100.5  Fever broke at 0600... sweaty! Woke up at 0800 with headache and foggy Felt normal by 1400 on 1/26
A non-serious spontaneous report of two patients were administered expired FLUMIST was received from a health professional concerning a five-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 23-Jan-2011. The patient received the expired FLUMIST on 24-Jan-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. Additional information was received on 03-Mar-2011: Reporter confirmed that neither of the two patients experienced any adverse events after receiving the expired FLUMIST.
Patient first said she felt dizzy and lightheaded.  Within 5 minutes, she said her fingers were tingling, face felt numb, and chest felt heavy.  Then she said her right rib cage area had extreme pain.  She said she was having difficulty breathing and was in pain.  911 had been called and firefighters then paramedics arrived and took her to ER.
Inflammation in the gums, white spots, deep red inflammation/swelling; Inflammation in the gums, white spots, deep red inflammation/swelling; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL SWELLING (Inflammation in the gums, white spots, deep red inflammation/swelling) and GINGIVAL DISORDER (Inflammation in the gums, white spots, deep red inflammation/swelling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 042L20A) for COVID-19 vaccination.     The patient's past medical history included Leukemia. Concomitant products included LOSARTAN, LEVOTHYROXINE and ANASTROZOLE (ANASTRAZOLE DENK) for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GINGIVAL SWELLING (Inflammation in the gums, white spots, deep red inflammation/swelling) and GINGIVAL DISORDER (Inflammation in the gums, white spots, deep red inflammation/swelling). At the time of the report, GINGIVAL SWELLING (Inflammation in the gums, white spots, deep red inflammation/swelling) and GINGIVAL DISORDER (Inflammation in the gums, white spots, deep red inflammation/swelling) had not resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had seen 3-4 doctors and a biopsy on gums to rule out lupus, oral surgeon could not diagnose. The symptoms are still ongoing, The treatment medication included Antibiotics (unspecified).   This case was linked to MOD-2021-366461 (Patient Link).
Patient received ZOSTAVAX vaccine on 10/21/11. On 10/24/11, patient came back & showed her back arm was very swollen & red.
PATIENT IS EXPERIENCING LEG CRAMPS IN BOTH LEGS AROUND THE  CALF AREA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 25-MAR-2021, the subject experienced subject is experiencing leg cramps in both legs around the calf area. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from patient is experiencing leg cramps in both legs around the calf area. This report was non-serious.
Hi, I received the Johnson and Johnson vaccine one week ago, Thurs March 11. On friday, I experienced the typical flu like symptoms - chills aches pains and fever. These have slowly gone away, but a week later I still have chills and constantly shake, and diarrhea. The most significant side effect I want to report is extreme vertigo and dizziness and headaches. These have been present for a week now and have prevented me from working and doing daily activities. I constantly feel like Im going to fall over and cannot see clearly. I previously had vestibular migraines, but these have been mostly gone due to going to the chiropractor and taking my supplements. The vaccine brought them back now in full force. I read that this is becoming a commonality among other people and need answers on this. I want to make sure its not permanent or that I will have this as a serious side effect.
At 2 am woke to severe chills and hyperventilating.  Took 45 minutes for everything to stop. (very scary) At 6:30 am began running a temp of 101.1.  Starting taking tylenol.  Fever never did go away.  Still had fever at 8 pm when I went to bed.  Woke up next morning and was fine.
Booster 1/2 dose administered/ should have received a full third dose for immunocompromised; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Booster 1/2 dose administered/ should have received a full third dose for immunocompromised) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 011A21A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (Booster 1/2 dose administered/ should have received a full third dose for immunocompromised). On 06-Dec-2021, ACCIDENTAL UNDERDOSE (Booster 1/2 dose administered/ should have received a full third dose for immunocompromised) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Around 10:00 p.m. the same day as receiving the shot, I started to experience intense burning sensation at the base of the back of my neck.  It persisted strongly and then body aches and chills started shortly therafter.  Now, on the second day, I noticed a feeling of bruising around the same base area of my neck and around the front left collar bone, it feels like a nerve/vein is swollen and tender.
Pfizer and EL8982 (1st dose) and EL8263(2nd dose) Date and time of vaccination: (list both if they received both shots): 01/18/2021 (1 st dose) and 02/08/2021 (2nd dose)  Did the adverse event start after the first or second vaccination? : both Date and time adverse event started: 01/18/2021 (1st dose) and 02/08/2021 (2nd dose) in the afternoon still having light headache (2nd dose: tylenol 500 mg tablets: 1 q8h as needed), but body aches have gone
A non-serious spontaneous report of expired FLUMIST administered was received from a health professional concerning a 12-year-old female. Neither medical history nor concomitant medication was reported for this patient. The FLUMIST expired on 29-Nov-2010. On 29-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 09-Mar-2011 and incorporated into case: no late occurring adverse events.
Pt came in for her second appointment. Pt stated that she had a initial reaction post vaccination. C/O tingling and warm sensation to her throat but was resolved immediately. Pt never mentioned to the nurse. Pt then stated that she had a reaction 2 day post vaccination. Pt complained of having multiple cold sores to mouth, tingling and itching sensation to nostrils and mouth. Pt attempted to call her PMD but no response. Called and messaged Dr, twice, no answer. Proceeded to call Dr. MD currently trying to reach pt's PMD to get clearance. Made pt aware of the plan.
Pt was found to have COVID and was admitted with suicidal ideation and depression, but is awaiting placement.
tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable pharmacist (patient's mother) via the regulatory authority.  This pharmacist reported similar events for 5 patients. This is the 3rd of 5 reports.   A 19-year-old female patient received BNT162B29 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration on 27Aug2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  On 20Sep2021, she tested positive for COVID, and didn't receive the second dose. The outcome of the event was unknown.   The lot number for the vaccine, BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to drug ineffectiveness cannot be ruled out.,Linked Report(s) : US-PFIZER INC-202101275398 same reporter, same drug, same event, different patient
big bump on it.; Black and blue 3x9In that does not hurt.; Sore arm later in the afternoon; arm is very swollen, Swollen below the injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of SKIN DISCOLOURATION, PAIN IN EXTREMITY, VACCINATION SITE SWELLING, and VACCINATION SITE in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE SWELLING. On 07-Jan-2022, the patient experienced PAIN IN EXTREMITY. On 09-Jan-2022, the patient experienced SKIN DISCOLOURATION. On an unknown date, the patient experienced VACCINATION SITE MASS. At the time of the report, SKIN DISCOLOURATION, PAIN IN EXTREMITY and VACCINATION SITE MASS outcome was unknown and VACCINATION SITE SWELLING had resolved with sequelae.            No concomitant medication was provided by the reporter.  Treatment medications which includes She used ice to alleviate the inflammation, after that she applied heath.
2 days p/vax pt devel an itchy, papular rash on the scalp;the rash spread to shoulders, back, chest, & arms;tx w/medrol dosepak;when the medrol was discontinued, the rash returned;
Employee received both of the above vaccines on 20 Mar 2019 to left arm. She noticed a quarter sized round red spot to back of left arm on 21 Mar 2019 at 1300. On the 22 Mar 2019, the red spot had increased to the size of a tennis ball 2x3" with redness, swelling, and induration which was warm and tender to the touch. The employee was told to come to Occupation Health immediately to be examined. Vital signs: WNL, afebrile. Employee was prescribed Cephalexin 500 mg PO four times daily for 7 days for soft tissue cellulitis infection. She was instructed to follow-up with Occupational Health 25 Mar 2019, which she did and cellulitis to left arm had improved drastically. Vital signs: WNL, afebrile.
Pt. reported feeling hot flashes immediately after vaccination. In about 1 minute, he felt better, but a few minutes later hot flashes returned along with dizziness. I instructed him to wait in pharmacy for at least 15 minutes. He felt better before leaving.
Deep vein thrombosis, legs blood clots, lungs pain, back in Hospital 10/31-11/2. Recovered on Eliquis for 6 months.
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Rash Generalized-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Severe, Systemic: Tachycardia-Medium, Additional Details: pt history of seizure disorder, did not mention  her last seizure was 2 days before vaccination. went unresponsive and had epipen given, then had several seizures and was taken by EMS
Patient states that during dinner time patient had inability to swallow. Patient also reports fatigue. After two days they were fine
Shingles on left arm. Symptom onset 3/20. Blisters are still open, nerve pain and itchiness persists as of today, 4/13. Taken acyclovir and methylprednisolone. Have already lost 2+ weeks of work.
Fever of 101.7 within 12 hours of the shot.  The fever lasted for 24 hours at different temps.  Chills and cold sweats for 24 hours.  A sever headache that lasted for 48 hours. About a week later, random sharp pains would radiate under my left breast.  They didn?t happen before the vaccine but I can?t verify they are occurring from the vaccine.
Symptoms lasted about a week. Pain, swelling, soreness, redness, itchiness, stiffness, red hot spot that spread over arm. Was unable to get allergy injections until following week. The booster received was the full dose.
slight rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (slight rash on her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (slight rash on her arm). At the time of the report, RASH (slight rash on her arm) outcome was unknown.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use not reported.   Treatment information not reported.
Under the site where I was given a shot above that I have a rash; Flu like symptoms; Fever; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN5813) via an unspecified route of administration on 10Feb2021 Wednesday (at the age of 67-year-old) as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization and had no reaction. On 11Feb2021, Thursday, patient experienced flu like symptoms, and had little bit of fever, that day and went away yesterday on 12Feb2021. At night on 12Feb2021, patient noticed that not directly, under the site where she was given a shot above that she had a rash and that was her concern, but it was not all over her body just under my arms not directly below the site but below it. Patient was taking Benadryl in response to the event rash. Outcome of the event flu and fever was resolved on 12Feb2021 and for rash was unknown.   Follow-up attempts completed. No further information expected.
Aches; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches) and FATIGUE (Tiredness) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN (Aches) and FATIGUE (Tiredness). At the time of the report, PAIN (Aches) and FATIGUE (Tiredness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-424596, MOD-2021-424597 (Patient Link).
About 2 weeks after the vaccine, I had a gout flare up on my left wrist and right large toe. I have a history of gout. I went to the doctor and the doctor prescribed colchicine and allopurinol. The gout did resolve and it took about 48 hours. I do get occasional flare ups and have had 5-6 episodes since then.
After injecting flu shot, pt. sat down and said that she has heavy chest. After few minutes, she has trouble breathing. 911 was called & arrived within 5 minutes. They gave pt. oxygen & after few minutes pt. felt better.
Bruising of left arm from shoulder to elbow for 2 weeks. Then at 2.5 weeks, lump develops at site of injection.